Amgen Reportable Segment — R&D increased by 8.9% to $1.90B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 31.0%, from $1.45B to $1.90B.
amgn_segment_reportable_segment_research_and_development| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $1.34B | $1.45B | $1.45B | $1.49B | $1.74B | $1.90B |
| QoQ Change | — | +7.7% | +0.2% | +2.5% | +17.4% | +8.9% |
| YoY Change | — | — | — | +10.6% | +20.5% | +31.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.